{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:54:39Z","timestamp":1790099679680,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.lfs.2022.120428","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T11:01:59Z","timestamp":1645614119000},"page":"120428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Hesperidin attenuates hepatic lipid accumulation in mice fed high-fat diet and oleic acid induced HepG2 via AMPK activation"],"prefix":"10.1016","volume":"296","author":[{"given":"Hao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penglu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.120428_bb0005","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2022.120428_bb0010","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1002\/jsfa.9478","article-title":"Ethanolic extract improves non-alcoholic fatty liver disease in mice fed a choline-deficient or high-fat diet","volume":"99","author":"Oh","year":"2019","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.lfs.2022.120428_bb0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/CS20070402","article-title":"Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations","volume":"115","author":"Preiss","year":"2008","journal-title":"Clin. Sci."},{"key":"10.1016\/j.lfs.2022.120428_bb0020","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1039\/C9FO00284G","article-title":"Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT\/SREBP-1\/FASN pathway","volume":"10","author":"Zhang","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.lfs.2022.120428_bb0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41575-021-00433-5","article-title":"What are the clinical settings and outcomes of lean NAFLD?","volume":"18","author":"Ren","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2022.120428_bb0030","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrgastro.2012.98","article-title":"NAFLD: the role of exercise in treating NAFLD","volume":"9","author":"Reynoso","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2022.120428_bb0035","first-page":"3290","article-title":"Protection mechanisms of hesperidin on mouse with insulin resistance","volume":"41","author":"Peng","year":"2016","journal-title":"China J. Chin. Mater. Medica."},{"key":"10.1016\/j.lfs.2022.120428_bb0040","first-page":"861","article-title":"Advance of Main chemical components and quality control of citri reticulatae pericarpium","volume":"30","author":"Siqi","year":"2020","journal-title":"Pharm. Today"},{"key":"10.1016\/j.lfs.2022.120428_bb0045","first-page":"11","article-title":"Effect of hesperidin on TLR4 and TRL9 expression in nonalcoholic fatty liver rats induced by high fructose and high fatty diet","volume":"22","author":"Xiaoxia","year":"2020","journal-title":"J. Liaoning Univ. TCM"},{"key":"10.1016\/j.lfs.2022.120428_bb0050","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ptr.5256","article-title":"Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models","volume":"29","author":"Parhiz","year":"2015","journal-title":"Phytother. Res."},{"key":"10.1016\/j.lfs.2022.120428_bb0055","first-page":"82","article-title":"Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome","volume":"96","author":"Stefano","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2022.120428_bb0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41430-020-0679-3","article-title":"The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial","volume":"75","author":"Yari","year":"2021","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.lfs.2022.120428_bb0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.lfs.2016.06.001","article-title":"Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress","volume":"157","author":"Xie","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2022.120428_bb0070","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2022.120428_bb0075","first-page":"131","article-title":"Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia","volume":"23","author":"Hatzitolios","year":"2004","journal-title":"Indian J. Gastroenterol."},{"key":"10.1016\/j.lfs.2022.120428_bb0080","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hep.21848","article-title":"Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial","volume":"46","author":"Lewis","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2022.120428_bb0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/cob.12068","article-title":"Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies","volume":"4","author":"Pallayova","year":"2015","journal-title":"Clin. Obes."},{"key":"10.1016\/j.lfs.2022.120428_bb0090","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1365-2036.2010.04467.x","article-title":"Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis","volume":"32","author":"Rakoski","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2022.120428_bb0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Ty","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.lfs.2022.120428_bb0100","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/ptr.5659","article-title":"Treatment of non-alcoholic fatty liver disease with curcumin: a randomized placebo-controlled trial","volume":"9","author":"Rahmani","year":"2016","journal-title":"Phytother. Res. Ptr."},{"key":"10.1016\/j.lfs.2022.120428_bb0105","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12967-016-0982-x","article-title":"Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease","volume":"14","author":"Chang","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lfs.2022.120428_bb0110","first-page":"3118","article-title":"Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study","volume":"19","author":"Aller","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2022.120428_bb0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4254\/wjh.v5.i3.109","article-title":"Silymarin in non alcoholic fatty liver disease","volume":"5","author":"Cacciapuoti","year":"2013","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.lfs.2022.120428_bb0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/liv.12975","article-title":"Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives","volume":"36","author":"Salomone","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.lfs.2022.120428_bb0125","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/acs.jafc.0c06652","article-title":"Diosmetin ameliorates nonalcoholic steatohepatitis through modulating lipogenesis and inflammatory response in a STAT1\/CXCL10-dependent manner","volume":"69","author":"Luo","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.lfs.2022.120428_bb0130","first-page":"405","article-title":"Optimal low-density lipoprotein cholesterol for cardiovascular prevention: how low should we go?","volume":"33","author":"Anderson","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.lfs.2022.120428_bb0135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mam.2018.03.001","article-title":"Omega-3 fatty acids and non-alcoholic fatty liver disease: evidence of efficacy and mechanism of action","volume":"64","author":"Scorletti","year":"2018","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.lfs.2022.120428_bb0140","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1039\/C9FO02237F","article-title":"Baicalein reduces hepatic fat accumulation by activating AMPK in oleic acid-induced HepG2 cells and high-fat diet-induced non-insulin-resistant mice","volume":"11","author":"WenlongSun","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.lfs.2022.120428_bb0145","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.lfs.2022.120428_bb0150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12944-016-0321-5","article-title":"Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease","volume":"15","author":"Paglialunga","year":"2016","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.lfs.2022.120428_bb0155","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.freeradbiomed.2019.06.019","article-title":"Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway","volume":"141","author":"Zhu","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2022.120428_bb0160","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.lfs.2022.120428_bb0165","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41586-018-0201-4","article-title":"Structural basis for regulation of human acetyl-CoA carboxylase","volume":"558","author":"Hunkeler","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2022.120428_bb0170","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12944-017-0464-z","article-title":"Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1\/AMPK\u03b1\/SREBP1 signaling pathway","volume":"16","author":"Wang","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.lfs.2022.120428_bb0175","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","article-title":"AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice","volume":"13","author":"Yu","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.lfs.2022.120428_bb0180","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.molmet.2014.04.010","article-title":"Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels","volume":"3","author":"Dahlhoff","year":"2014","journal-title":"Mol. Metab."},{"key":"10.1016\/j.lfs.2022.120428_bb0185","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1039\/D0FO02623A","article-title":"Plant sterol ester of \u03b1-linolenic acid ameliorates high-fat diet-induced nonalcoholic fatty liver disease in mice: association with regulating mitochondrial dysfunction and oxidative stress via activating AMPK signaling","volume":"12","author":"Han","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.lfs.2022.120428_bb0190","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1021\/acs.jafc.1c02596","article-title":"\u03b3-linolenic acid prevents lipid metabolism disorder in palmitic acid-treated alpha mouse liver-12 cells by balancing autophagy and apoptosis via the LKB1-AMPK-mTOR pathway","volume":"69","author":"Liang","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.lfs.2022.120428_bb0195","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metab. Clin. Exp."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052200128X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052200128X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:56:21Z","timestamp":1758401781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052200128X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":39,"alternative-id":["S002432052200128X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120428","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hesperidin attenuates hepatic lipid accumulation in mice fed high-fat diet and oleic acid induced HepG2 via AMPK activation","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120428"}}